v3.26.1
Condensed Statement of Changes in Stockholders' Equity (Unaudited) (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     26,960,901        
Beginning balance at Dec. 31, 2024 $ 1,654   $ 3   $ 57,924   $ (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 2,286       2,286    
Sale of Common Stock, net of issuance costs (in shares)     6,746,386 284,338      
Sale of Common Stock, net of issuance costs 10,250 $ 450   $ 1 10,250 $ 449  
Stock issuance upon exercise of stock options (in shares)     28,715        
Net loss (10,458)           (10,458)
Ending balance (in shares) at Jun. 30, 2025     34,020,340        
Ending balance at Jun. 30, 2025 4,182   $ 4   70,909   (66,731)
Beginning balance (in shares) at Mar. 31, 2025     33,734,548        
Beginning balance at Mar. 31, 2025 7,529   $ 3   69,283   (61,757)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 1,177       1,177    
Sale of Common Stock, net of issuance costs (in shares)       284,338      
Sale of Common Stock, net of issuance costs 450     $ 1 449    
Stock issuance upon exercise of stock options (in shares)     1,454        
Stock issuance upon exercise of stock options 0       0    
Net loss (4,974)           (4,974)
Ending balance (in shares) at Jun. 30, 2025     34,020,340        
Ending balance at Jun. 30, 2025 $ 4,182   $ 4   70,909   (66,731)
Beginning balance (in shares) at Dec. 31, 2025 40,117,404   40,117,404        
Beginning balance at Dec. 31, 2025 $ 2,603   $ 4   79,887   (77,288)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense $ 2,918       2,918    
Sale of Common Stock, net of issuance costs (in shares) 14,375,000 970,467 14,375,000 970,467      
Sale of Common Stock, net of issuance costs $ 10,265 $ 1,515 $ 2   10,263 $ 1,515  
Stock issuance upon exercise of stock options (in shares) 35,000   35,000        
Stock issuance upon exercise of stock options $ 10       10    
Stock issuance upon vesting of restricted stock units (in shares)     738,940        
Stock issuance upon vesting of restricted stock units 505       505    
Stock issuance upon settlement of liability, (in shares)     112,360        
Stock issuance upon settlement of liability 100       100    
Net loss $ (9,739)           (9,739)
Ending balance (in shares) at Jun. 30, 2026 56,349,171   56,349,171        
Ending balance at Jun. 30, 2026 $ 8,177   $ 6   95,198   (87,027)
Beginning balance (in shares) at Mar. 31, 2026     41,131,835        
Beginning balance at Mar. 31, 2026 635   $ 4   82,619   (81,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 1,701       1,701    
Sale of Common Stock, net of issuance costs (in shares)     14,375,000        
Sale of Common Stock, net of issuance costs 10,265   $ 2   10,263    
Stock issuance upon exercise of stock options (in shares)     35,000        
Stock issuance upon exercise of stock options 10       10    
Stock issuance upon vesting of restricted stock units (in shares)     694,976        
Stock issuance upon vesting of restricted stock units 505       505    
Stock issuance upon settlement of liability, (in shares)     112,360        
Stock issuance upon settlement of liability 100       100    
Net loss $ (5,039)           (5,039)
Ending balance (in shares) at Jun. 30, 2026 56,349,171   56,349,171        
Ending balance at Jun. 30, 2026 $ 8,177   $ 6   $ 95,198   $ (87,027)